The FDA advises against using NSAIDs from 20 weeks of pregnancy onward due to risk of kidney issues in the fetus
encoded by the CYCS gene)
Structurally, GLP-1 agonists can be categorized into two groups: those with a human GLP-1 backbone (including dulaglutide, albiglutide, liraglutide, and semaglutide) and those with an exendin-4 backbone (such as exenatide in its various formulations and lixisenatide) [64]
What if I want to stop GLP-1 drugs completely
Diabetology & Metabolic Syndrome, 14 (1), 93
Lipase inhibitors take a different approach entirely, reducing dietary fat absorption in the gastrointestinal tract, lowering caloric intake mechanically rather than through central nervous system signaling